Business Context and Reporting Period
This Form 8-K is filed by Aethlon Medical, Inc. (Nasdaq: AEMD), a Nevada corporation, on November 6, 2025. The report addresses a corporate governance event regarding the company's listing status on The Nasdaq Capital Market.
Key Financial Metrics
This filing is a Current Report (Item 8.01 Other Events) and does not contain financial statements. Consequently, there are no reported values for revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes
The material change reported is the resolution of a listing deficiency:
- Previous Status: On October 16, 2025, Nasdaq notified the company of non-compliance with the Minimum Bid Price Requirement (Rule 5450(a)(2)) because the common stock closed below $1.00 per share for 30 consecutive business days.
- Resolution: On November 5, 2025, Nasdaq confirmed the company regained compliance by maintaining a closing bid price of at least $1.00 per share for ten consecutive business days.
- Current Status: The matter is now closed, and the company remains listed on The Nasdaq Capital Market.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on operations, or discussion of new risks. The primary risk addressed was the potential delisting due to low stock price, which has been mitigated by the regained compliance.
Investor Verification Checklist
- Verify the current trading price of AEMD to ensure it remains above the $1.00 threshold to avoid future non-compliance notices.
- Review the October 16, 2025, 8-K filing for the initial notice of non-compliance details.
- Check subsequent filings (10-Q or 10-K) for the company's actual financial performance, as this 8-K contains no financial data.